Home » India

India

CND Reconvened 67th Session

Chair: Welcome back to the Reconvened 67th Session. We will continue the consideration on Item 4 on strategic management, budgetary and administrative questions. At our joint meeting with the CCPCJ yesterday, we considered under Agenda Item 4 the implementation of the consolidated for the biennium 2024-2025 for the UNODC. And the drugs proposed program plan …

Read more

Item 5. Implementation of the international drug control treaties (Tuesday morning)

Chair: We will consider scheduling recommendations by WHO and INCB.  CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …

Read more

Round Table 2 – The Way Forward: The Road to 2029

Germany/Chair: Hello, welcome to our discussion regarding the way forward in advancing the implementation of all international drug policy commitments in light of the 2029 finally view of certain 2019 Ministerial Declaration in accordance with CND Resolution 66 Adopted by the Commission last March, this roundtable will consist of panel interventions followed by an interactive …

Read more